Asian healthcare investment booms, offers ‘double bottom line’ for private equity

Asian healthcare investment booms, offers ‘double bottom line’ for private equity

A man holds medicinal pills in his hand. Photo: Volodymyr Hryshchenko/unsplash

Healthcare-focused private equity firm Quadria Capital has what may be called a leisurely approach to investing in what is an increasingly active sector.

It can work two to three years with a potential portfolio company, sometimes even on a pro-bono basis, before its partners make a decision to invest in it. But the fund’s limited partners do not complain, Amit Varma, managing partner at Quadria Capital, said in a recent interview with DealStreetAsia. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter